FABP3 and amyloidosis: However, previous research has demonstrated significantly elevated GOT activity in the brains of Alzheimer’s patients [58, 59].Elevated levels of FABP3 have been demonstrated to be associated with an increased likelihood of amyloid pathology [60] .